---
$id: https://graph.org.ai/products/commodity/51111660
$type: Product
source: UNSPSC
code: "51111660"
title: "Triciribine"
class: "51111600"
classTitle: "Antimetabolites"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Triciribine

**UNSPSC Code**: 51111660
**Class**: [Antimetabolites](Antimetabolites.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a purine antagonist and inosine monophosphate dehydrogenase inhibitor and amidophosphoribosyltransferase inhibitor with the molecular formula C13H16N6O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2421HMY9N6, chemically known as 1,4,5,6,8-pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-d-ribofuranosyl- (9ci) but generally known as triciribine, which bears US NIH Compound Identifier 65399. European Medicines Agency schedules Triciribine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11266MIG. The term TRICIRIBINE is an International Non-Proprietary Name. TRICIRIBINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule triciribine under HS 29349990 and SITC 51579. As of Q4 2014, TRICIRIBINE remains the US FDA Preferred Term for this commodity. SMILES: O1C(N2C3NCNC4N(NC(N)C(C2)C34)C)C(O)C(O)C1CO.

